Stranger than fiction.

Profit falls from a year earlier.

Oil rises $1.95 to $66.03 a barrel.

The PC maker discovers evidence of accounting misconduct.

The business software maker beats sales and profit estimates, but EPS guidance is a bit soft.

Shares slide after Morgan Stanley takes a bearish view of the executive departure.

It will slash staffing by 15%.

The discount retailer has improved its performance, but its stock isn’t a bargain.

It reiterates its claim that the FBI isn’t involved.

The company’s prostate cancer vaccine wins a 13-4 vote.

The drug is sold generically as pergolide and under the brand name Permax.